drugset / Trial / NCT02010034

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

NCT02010034

Completed 15 enrolled Children's Medical Center Dallas
NaSingle-groupOpen-labelSupportive care

Summary

This study is being done to determine if an investigational study drug called Omegaven can help to improve liver disease thought to be caused by Total Parenteral Nutrition (TPN). TPN is intravenous feeding (IV feeding tube) that provides patients the nutrients when they are unable to drink fluid or eat food by mouth.

Timeline

Start
2013-08
Primary completion
2019-02-05
Completion
2019-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Omegaven Other / unclassified 1 g/kg Intravenous

Indications